CID 126715380

Golidocitinib

Structural Information

Molecular Formula
C25H31N9O2
SMILES
C[C@H](C(=O)NC1=CC=CC2=C1NC=C2C3=NC(=NC=C3)NC4=CN(N=C4OC)C)N5CCN(CC5)C
InChI
InChI=1S/C25H31N9O2/c1-16(34-12-10-32(2)11-13-34)23(35)28-20-7-5-6-17-18(14-27-22(17)20)19-8-9-26-25(29-19)30-21-15-33(3)31-24(21)36-4/h5-9,14-16,27H,10-13H2,1-4H3,(H,28,35)(H,26,29,30)/t16-/m1/s1
InChIKey
CVCVOSPZEVINRM-MRXNPFEDSA-N
Compound name
(2R)-N-[3-[2-[(3-methoxy-1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1H-indol-7-yl]-2-(4-methylpiperazin-1-yl)propanamide
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

3
References

173
Patents

489.26007 Da
Monoisotopic Mass

1.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 490.26735 214.8
[M+Na]+ 512.24929 226.2
[M+NH4]+ 507.29389 217.6
[M+K]+ 528.22323 225.4
[M-H]- 488.25279 218.5
[M+Na-2H]- 510.23474 220.7
[M]+ 489.25952 217.0
[M]- 489.26062 217.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe